Immunosuppressive Drugs Market Size Value, Share Estimation, Growth Trends and Industry Insights

Immunosuppressive Drugs Market Size, Trends and Share Analysis By Drug Type (Calcineurin Inhibitors, Corticosteroids, Antiproliferative Agents, mTOR Inhibitors, Others), By Route of Administration (Intravenous, Oral, Others), By Application (Autoimmune Disease, Organ Transplant, Kidney Transplant, Heart Transplant, Others) and By End User (Hospitals and Clinics, Organ Transplant Centers, Others) – Forecast to 2025

Immunosuppressive Drugs Market Overview

MRFR (Market Research Future) projects exciting prospects for the immunosuppressive drugs market size to cross USD 1.39 Billion by 2025. It is also presumed that the market size can burgeon at a rate of 4.63% between 2019 and 2025 (analysis period). We will provide COVID-19 impact analysis with the report, along with all the extensive key developments in the market post the coronavirus disease outbreak.

The novel coronavirus has been a huge deterrent for the immunosuppressive drugs industry worldwide. Individuals dealing with chronic conditions or autoimmune diseases are believed to be extremely vulnerable to the SARS-CoV-2 infection. Even the elderly patients are at high risk of being affected by the pandemic. But, the COVID-19 impact on the organ transplantation industry has been substantially brutal, emerging as a life-threatening event for organ transplant recipients.

Request Free Sample Copy of the report “Immunosuppressive Drugs Market Research Report - Global Forecast till 2025” at: https://www.marketresearchfuture.com/sample_request/8228

Despite the worldwide lockdown, the COVID-19 has been spreading exponentially and has been significantly restricting the transplantation system in the highly affected locations owing to the extreme chances of SARS-CoV-2 among immunosuppressed patients, transmission risks among healthcare staff and more. Also, travel bans have been unfavorable for organ procurement organizations/OPOs and, have led to shortage of medical services across the world, be it developed or developing nations.

Increase in organ transplantation across the globe has been the result of the rising burden of various genetic conditions such as heart defect, polycystic kidney disease and cystic fibrosis. Rise in hepatitis cases, damaged organs owing chronic disorders such as diabetes and physical injuries are some of the other growth boosters for organ transplants, leading to higher need for immunosuppressive drugs. These drugs come into the picture after the organ transplant procedure, helping patient's immune system deal with the hyper-immune response. In a nutshell, the escalating need for organ transplantation procedures across the world has bolstered the demand for effective immunosuppressive drugs and could be favorable for the global market in the following years.

With the amplifying demand for transplantation and the rising frequency of technological innovations in organ transplants as well as tissue engineering, the market is bound to expand significantly in the next few years. From the competitive standpoint, various players are undertaking strategies such as business expansions, collaborations and product advancement, to gain leverage in the global market. Increasing green light from the FDA is also encouraging top players to come up with more efficient drugs in the market. To cite an instance, in November 2020, Lupin, in collaboration with Concord Biotech, got the approval from FDA to sell Tacrolimus capsules, generic immunosuppressive drugs, in the US market. These capsules help treat organ rejection in pediatric and adult patients that are undergoing allogeneic kidney, heart or liver transplants, combined with various other immunosuppressant drugs.

Immunosuppressive Drugs Market Opportunities

Pharmaceutical and biopharmaceutical firms are spending considerably on R&D activities in terms of immunosuppressive drugs, which helps boost the market’s growth potential. Additionally, substantial demand for highly reliable and efficient immunosuppressive drugs for treating chronic autoimmune disorders and avoiding organ rejection in individuals undergoing organ transplantation could be a lucrative opportunity for the key contenders in the global market.

Immunosuppressive Drugs Market Segmental Analysis

Immunosuppressive drugs market has been categorized on the basis of drug type, route of administration, application, and end user.

The drug types considered in the market study include IMDH inhibitors, corticosteroids, calcineurin inhibitors, mTOR inhibitors, antiproliferative agents, and others. The calcineurin inhibitors segment will most like take the lead in the global market, given their high efficacy and the resultant rise in the demand for these drugs post organ transplantation procedures. The corticosteroids segment can however, secure the fastest advancement rate since healthcare professionals are progressively opting for these drugs.

The main routes of administration are oral, intravenous, and more. Intravenous route of administration could emerge as the biggest segment while the oral route can be the fastest expanding segment.

Immunosuppressive drugs’ key applications are organ transplant, autoimmune disease, and others. Autoimmune diseases should be the top segment in the coming years on account of the rising cases of autoimmune disorders including multiple sclerosis, systemic lupus erythematosus and rheumatoid arthritis. On the other hand, the highest growth rate will be secured by the organ transplant segment, given the expanding pool of transplant donors along with the surge in organ transplantations.

The key market end-users can be organ transplant centers, hospitals and clinics, and others. The hospitals and clinics category is likely to obtain the leading position owing to the significant rise in patient admissions combined with the growth in the number of hospitals, especially in emerging countries. The organ transplant centers segment could leap ahead at the highest growth rate, as the deployment of immunosuppressants after the transplant procedures is increasing at a promising rate.

Immunosuppressive Drugs Market Regional Study

Europe and APAC/Asia Pacific along with Americas and MEA/Middle East and Africa are the primary markets for immunosuppressive drugs across the world.

With the highest number of organs transplants every year and significant burden of autoimmune diseases, it is no surprise that America has taken the lead in the immunosuppressive drug market. Frequent technical advances and considerable spending on extensive R&D can also be credited for the strong market growth in the region. Large-scale government funding, and the well-developed healthcare infrastructure along with a huge pool of skilled medical professionals also add to the market value.

Despite a lower burden of autoimmune diseases compared to Europe and the Americas, the exploding population and the surging need for organ transplants boost APAC’s chances of achieving the fastest growth rate in the coming years. Low healthcare costs could be one of the reasons for the recent surge in medical tourism, which has furthered the need for effective immunosuppressive drugs. Also, encouraging government initiatives in the form of large-scale funding and rising focus of the manufacturers on research and development activities are a few unexplored avenues that could translate to high revenues in the ensuing years.

Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/immunosuppressive-drugs-market-8228

Immunosuppressive Drugs Market Key Companies

The key companies operative in the worldwide market are Glenmark Pharmaceuticals, Inc (India), Genzyme Co. (US), Zydus Cadila (India), Novartis AG (Switzerland), Pfizer Inc. (US), Actavis, Inc. (US), Mylan Laboratories Inc. (US), F. Hoffmann-La Roche AG (Switzerland), Accord Healthcare (US), Astellas Pharma (Japan), Bristol-Myers Squibb Company (US), GlaxoSmithKline PLC (UK), to mention a few.

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

This release was published on openPR.